GenMark Diagnostics announced that its board of directors has appointed Hany Massarany as the company's president, chief executive officer, and a member of the board.
Previously, Massarany was president of Ventana Medical Systems and head of Roche Tissue Diagnostics. Before that, he held executive management positions with Bayer Diagnostics and Chiron Diagnostics. Massarany will replace Christopher Gleeson, who has been serving as the interim CEO of GenMark.
GenMark has also tapped Paul Ross to serve as chief financial officer, a position he will assume in April. Ross currently is CFO at Teledata, and he formerly held the same position at Meade Instruments and at Power-One.
MDxHealth announced the formation of a scientific advisory board, members of which will support the company's strategic initiatives.
The members include Jonathan Epstein, director of surgical pathology at Johns Hopkins University School of Medicine; James Herman, professor of oncology at the Oncology Center at Johns Hopkins Medical Institutions; Gerrit Meijer, chair of the pathology department at the Free University Medical Center in Amsterdam; and Eric Wallen, associate professor of surgery in the urology division at the University of North Carolina Medical Center, Chapel Hill.